Navigation Links
MedImmune To Present Eight Abstracts on Projects Regarding Thoracic and Respiratory Issues at the Annual American Thoracic Society International Conference
Date:5/13/2011

GAITHERSBURG, Md., May 13, 2011 /PRNewswire/ -- MedImmune announced today it will present eight abstracts at the American Thoracic Society (ATS) International Conference in Denver, CO, May 13-18, 2011.  "These data advance our understanding of thoracic diseases, highlighting our continued commitment to help improve patient health," said Bing Yao, Senior Vice President and Leader of the RIA innovative Medicines Unit (iMED) at MedImmune.

MedImmune abstracts to be presented at the ATS International Conference include:

  • IL-1 Family Members Have Different Effects on the Innate Pro-inflammatory and Anti-viral Responses of Epithelial Cells to Rhinovirus. Briend E, et al. Poster Session: May 16, 2011 Time: 10:45 - 12:30 PM,  Colorado Convention Center Area J, Hall B (Upper Level)
  • Cytokine Profiling in Severe Asthma Sub-phenotypes Using Factor and Cluster Analysis. Desai D, et al. Poster Session: May 16, 2011 Time: 3 - 3:15 PM, HRD Ballroom A-B-C (3rd Level)
  • Expression Patterns of Interleukin-1 Receptor 1 in COPD Patients, Smokers and Never-smoking Control Subjects. Bergqyist A, et al. Poster Session: May 16, 2011 Time: 8:15 AM – 4:30 PM, Colorado Convention Center Area E, Hall B (Upper Level)
  • Full Length IL-33 Activates Primary Human Mast Cells and It's Inhibited by Neutralising Antibodies. Cohen S, et al. Poster Session: May 17, 2011 Time: 8:15 AM – 4:30 PM, Colorado Convention Center Area F, Hall B (Upper Level)
  • The Epithelial-derived Signals TSLP, IL-25 and IL-33 Converge on OX40L to Elicit House-dust Mite 0 Induced Allergic Airway Inflammation in Mice. Llop-Guerva A, et al. Poster Session: May 16, 2011 Time: 8:15 AM – 4:30 PM, Colorado Convention Center Area K, Hall B (Upper Level)
  • In Vitro Cellular Response to Respiratory Syncytial Virus and Human Rhinovirus Infection of Primary
    '/>"/>

SOURCE MedImmune
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Pfenex Announces Strategic Collaboration With MedImmune for the Use of Pfenex Expression Technology™
2. MedImmune to Present 11 Abstracts on Influenza at 45th Annual National Immunization Conference
3. MedImmune In-Licenses Clinical-Stage Anti-Inflammatory Monoclonal Antibody From Amgen
4. MedImmune Announces Winners of the 5th Annual Respiratory, Inflammation and Autoimmunity Research Abstract Competition
5. MedImmune Focused on Revolutionizing Cancer Care
6. MedImmune to Present Five Abstracts on RSV at Pediatric Academic Societies Annual Meeting
7. MedImmune to Present Data on RSV and Influenza at 2009 American Academy of Pediatrics National Conference & Exhibition
8. MedImmune Funds Study to Help Gain Insights Into Full Burden of RSV Disease Among Premature Infants
9. MedImmune Presents New Data Demonstrating Increased Risk for Medically Attended RSV in Late-Preterm Infants
10. MedImmune Advances Pediatric Disease Prevention Program With Start of Phase 1/2a Clinical Trial for Respiratory Syncytial Virus Vaccine
11. Micromet and MedImmune Commence Treatment in Phase 2 Trial of BiTE Antibody Blinatumomab (MT103/MEDI-538) in Patients with Acute Lymphoblastic Leukemia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2013)... 2013 The Board of Directors of Boston ... as a Director.  The appointment of Mr. Roux ... Board,s decision to increase the number of directors comprising ... the number of directors and Mr. Roux,s appointment to ... Mr. Roux is a co-founder and Senior ...
(Date:12/16/2013)... Pa. , Dec. 16, 2013  Lankenau Heart Institute,s ... completed his 1000 th coronary artery bypass (CABG) procedure ... his heart back for the holidays. Dr. Sutter has performed ... His 1000 th surgery was performed on Morrie ... due to severe blockage in his arteries. Richfield returned to ...
(Date:12/16/2013)... and SAYREVILLE, N.J., Dec. 16, 2013 Avista Capital ... / Trigen Holdings ("Vertical / Trigen" or "the Company"), ... that Avista has acquired a controlling equity interest in ... Steven Squashic , Kevin Hudy , and ... retain a significant minority ownership stake in the Company. ...
Breaking Medicine Technology:Boston Scientific Elects David Roux To Its Board of Directors 2Lankenau Heart Institute Cardiac Surgeon Reaches Historic Milestone In Robotic Heart Procedure 2Lankenau Heart Institute Cardiac Surgeon Reaches Historic Milestone In Robotic Heart Procedure 3Avista Capital Partners Announces a Majority Investment in Vertical Pharmaceuticals and Trigen Laboratories 2Avista Capital Partners Announces a Majority Investment in Vertical Pharmaceuticals and Trigen Laboratories 3
... WOONSOCKET, R.I., April 6, 2012  CVS Caremark (NYSE: ... the Most Reputable Companies in America by Reputation Institute, ... based on Reputation Institute,s 2012 U.S. RepTrak™ Pulse, a ... (Logo: http://photos.prnewswire.com/prnh/20090226/NE75914LOGO ) ...
... BURLINGTON, Mass., April 6, 2012 /PRNewswire-iReach/  -- ... announced today that they have entered into a ... the Medicare Set Aside, Medical Cost Projection, and ... Medicare Solutions.  (Photo: http://photos.prnewswire.com/prnh/20120406/CG83519 ...
Cached Medicine Technology:CVS Caremark Ranks Among Top 25 Most Reputable Companies in America on Forbes List 2Ametros Financial and Ringler Medicare Solutions Announce Partnership to Provide Professional Administration Services 2
(Date:12/17/2013)... pressure affects approximately one in three adults in ... and one billion people worldwide. Because of this ... and the International Society of Hypertension (ISH) are ... for the diagnosis and treatment of Hypertension: ... in the Community." These are the first ...
(Date:12/17/2013)... 17, 2013 A Newark treatment center ... prescription drug abuse in New Jersey through Drug Addiction Treatment ... Jersey medical examiner has revealed that prescription drug abuse led ... 2011 and 2012. Dr. Roger Mitchell compared those statistics to ... , Mitchell also revealed additional statistics. The ...
(Date:12/17/2013)... The Herbst Device from Respire Medical is ... Medical is one of the handful of dental labs ... oral sleep device. Dental Sleep Medicine education will ... to learn more about treating patients for snoring and sleep ... announce that Respire has received Medicare approval for our Respire ...
(Date:12/17/2013)... expressed in normal colonic cells and is activated ... proliferation, survival and differentiation. Increased expression and activation ... majority of colorectal carcinoma (CRC), suggesting that the ... carcinogenesis. , The monoclonal antibodies cetuximab and ... have shown clinical activity in patients with metastatic ...
(Date:12/17/2013)... Seattle, WA (PRWEB) December 17, 2013 ... program aimed at helping people end their dependency upon drugs ... Center. , According to a report from the ... 2.9 million persons aged 12 or older in 2012 who ... 12 months, a majority reported that their first drug was ...
Breaking Medicine News(10 mins):Health News:New hypertension guidelines offer practical, clinical information for doctors and patients around the globe 2Health News:Newark Treatment Center Announces Program to Battle Prescription Drug Substance Abuse 2Health News:The Herbst Device by Respire Medical is FDA Cleared and Now Medicare PDAC Approved 2Health News:The Herbst Device by Respire Medical is FDA Cleared and Now Medicare PDAC Approved 3Health News:Seattle Drug Detox Center Launches New Program to Help People Stop Dependency on Cocaine, Heroin and Prescription Drugs 2
... to Remember Those Taken by Lou Gehrig,s Disease. , ... Calabasas Hills, ... D.C., for a candlelight vigil on Sunday, May 10 on the steps ... Day and Public Policy Conference to show its solidarity in the fight ...
... Physicians for Human Rights and a coalition of organizations from more than ... Iranian government to drop the charges and immediately release Kamiar and Arash ... ... celebrates the release of detained US journalist Roxana Saberi, there is still ...
... The American College of Medical Genetics Foundation (ACMGF) ... its 2009 annual meeting. The board members are active ... for advancing the policies and programs of the ACMGF.The ... years, are: Wayne W. Grody, M.D., Ph.D., FACMG , ...
... Resources Allows Pharmaceutical Brand Managers to Build Patient-Flow ... 11 Decision Resources, one of the world,s ... and healthcare issues, finds that use of Novartis, ... Merck,s Cozaar is influenced by physician perception that ...
... be based in the northwest region with more ... yearHARRISBURG, Pa., May 11 The Pennsylvania Patient ... for the northwest region to help healthcare facilities ... System (PA-PSRS) improve patient safety for Pennsylvania citizens. ...
... (Nasdaq: MSON ), a developer of minimally invasive ... the ablation of tumors and worldwide for other acute health ... months ended March 31, 2009. Michael A. McManus, Jr., ... and Chief Financial Officer, will host a conference call Tuesday, ...
Cached Medicine News:Health News:Through Light There Is Hope 2Health News:Saberi Release Highlights Case of Imprisoned Iranian AIDS Doctors 2Health News:Saberi Release Highlights Case of Imprisoned Iranian AIDS Doctors 3Health News:New Board Members Join American College of Medical Genetics Foundation (ACMGF): Distinguished Executive, Medical and Philanthropic Leaders Bring Additional Perspectives to the ACMGF Board 2Health News:New Board Members Join American College of Medical Genetics Foundation (ACMGF): Distinguished Executive, Medical and Philanthropic Leaders Bring Additional Perspectives to the ACMGF Board 3Health News:More Patients Receive Diovan As A First- Or Second-Line Therapy Compared With Cozaar or Avapro 2Health News:More Patients Receive Diovan As A First- Or Second-Line Therapy Compared With Cozaar or Avapro 3Health News:Pennsylvania Patient Safety Authority Hires Patient Safety Liaison to Help Healthcare Facilities Implement Guidance 2Health News:Pennsylvania Patient Safety Authority Hires Patient Safety Liaison to Help Healthcare Facilities Implement Guidance 3Health News:Misonix Reports Earnings for the Three and Nine Months Ended March 31, 2009 2Health News:Misonix Reports Earnings for the Three and Nine Months Ended March 31, 2009 3Health News:Misonix Reports Earnings for the Three and Nine Months Ended March 31, 2009 4Health News:Misonix Reports Earnings for the Three and Nine Months Ended March 31, 2009 5Health News:Misonix Reports Earnings for the Three and Nine Months Ended March 31, 2009 6Health News:Misonix Reports Earnings for the Three and Nine Months Ended March 31, 2009 7Health News:Misonix Reports Earnings for the Three and Nine Months Ended March 31, 2009 8Health News:Misonix Reports Earnings for the Three and Nine Months Ended March 31, 2009 9Health News:Misonix Reports Earnings for the Three and Nine Months Ended March 31, 2009 10
Avitene Microfibrillar Collagen Hemostat (MCH) is used in surgical procedures as an adjunct to hemostasis when control of bleeding by ligature or conventional procedures is ineffective or impractical...
Avitene Microfibrillar Collagen Hemostat (MCH) is used in surgical procedures as an to hemostasis when control of bleeding by ligature or conventional procedures is ineffective or impractical....
Avitene Microfibrillar Collagen Hemostat (MCH) is used in surgical procedures as an adjunct to hemostasis when control of bleeding by ligature or conventional procedures is ineffective or impractical...
... device restores lordosis and ... less reaming of the ... Danek's Tapered Laparoscopic Instruments ... and reproducibly place the ...
Medicine Products: